Women are routinely invited under the national cervical check program every three to five years for cervical screening.
A smear test is carried out to detect any changes in the cervix. During the test some cells are removed from the neck of
the womb and examined microscopically to look for changes that could develop into cervical cancer.
The results can be recorded as follows:
CIN 1 – Mild abnormalities in the cells of the cervix
CIN 2 – Moderate abnormalities in the cells of the cervix
CIN 3 – Severe abnormalities in the cells of the cervix
In Ireland approximately 300 women are diagnosed with invasive cervical cancer each year.
It is the second most common female cancer in Europe.
What information should my client provide?
Your customer should complete the Gynaecology fast-track questionnaire
Likely Underwriting Acceptance:
|Specified Illness Cover
|CIN 2 & 3 completely excised with no invasion
Please note that likely acceptance terms are indicative only and cases are subject to full underwriting.